US20050175659A1 - Collagen device and method of preparing the same - Google Patents

Collagen device and method of preparing the same Download PDF

Info

Publication number
US20050175659A1
US20050175659A1 US10/955,835 US95583504A US2005175659A1 US 20050175659 A1 US20050175659 A1 US 20050175659A1 US 95583504 A US95583504 A US 95583504A US 2005175659 A1 US2005175659 A1 US 2005175659A1
Authority
US
United States
Prior art keywords
collagen
sheet
active agent
biological active
pores
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/955,835
Other languages
English (en)
Inventor
Laurel Macomber
Robert Sommerich
Vivek Shenoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Codman and Shurtleff Inc
Original Assignee
Codman and Shurtleff Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codman and Shurtleff Inc filed Critical Codman and Shurtleff Inc
Priority to US10/955,835 priority Critical patent/US20050175659A1/en
Assigned to CODMAN & SHURTLEFF, INC. reassignment CODMAN & SHURTLEFF, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HALVORSEN, MATTHEW J., MACOMBER, LAUREL R., SOMMERICH, ROBERT E., SHENOY, VIVEK N.
Priority to AU2005200378A priority patent/AU2005200378B2/en
Priority to KR1020050010497A priority patent/KR101232099B1/ko
Priority to TW094103484A priority patent/TWI445521B/zh
Priority to EP10179802.3A priority patent/EP2289569B1/en
Priority to CA2496187A priority patent/CA2496187C/en
Priority to ARP050100442A priority patent/AR048064A1/es
Priority to ES10179802.3T priority patent/ES2626126T3/es
Priority to EP05250694.6A priority patent/EP1561480B1/en
Priority to ES10179803T priority patent/ES2398716T3/es
Priority to EP10179803A priority patent/EP2289570B1/en
Priority to SG200500714A priority patent/SG114709A1/en
Priority to CN 200510051850 priority patent/CN1817371B/zh
Priority to ES05250694.6T priority patent/ES2563305T3/es
Priority to MXPA05001602A priority patent/MXPA05001602A/es
Priority to BRPI0500456A priority patent/BRPI0500456A8/pt
Priority to CO05062169A priority patent/CO5590175A1/es
Priority to US11/171,638 priority patent/US20050283256A1/en
Publication of US20050175659A1 publication Critical patent/US20050175659A1/en
Priority to US12/196,621 priority patent/US8795710B2/en
Priority to AU2011201382A priority patent/AU2011201382B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
    • A61B5/02233—Occluders specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen

Definitions

  • the present invention relates to a collagen device and a method of preparing the same. More specifically, the present invention relates to a method for preparing a collagen device for use as an implant to replace, reinforce or strengthen bodily tissue, an adhesion barrier, or for use as a short-term body contact for moisture retention, hemostasis or tissue protection.
  • meningeal membranes whose integrity is critical to the operation of the central nervous system.
  • meningeal membranes When the integrity of a person's meningeal membranes is intentionally or accidentally compromised, serious consequences may ensue, unless the membranes can be repaired.
  • the meningeal membrane comprises three overlapping layers of tissue, which are in order from outside to inside, the dura mater (or dura), the arachnoid and the pia mater. Repairing damaged meningeal membranes has largely focused on implantable and/or resorbable constructs (known as dural substitutes) which are grafted to the damaged dura mater and are designed to replace and/or regenerate the damaged tissue.
  • implantable and/or resorbable constructs known as dural substitutes
  • the present invention is directed to a collagen device that has a plurality of pores wherein a majority of the pores have a diameter of less than 10 ⁇ m.
  • the collagen device made in accordance with the present invention has good handling properties, as the collagen device is sufficiently flexible to conform to irregular-shaped surfaces but stiff enough that it does not curl or adhere to itself, instruments or the practitioner's gloved hands when wet.
  • the collagen device in accordance with the present invention has very good strength properties, such as tensile strength, making it very easy to handle for the physician.
  • the collagen device in accordance with the present invention can be made the same shape or size as conventional collagen devices, such as currently available collagen dural grafts, while still providing the surgeon with a device that has superior strength and handling properties.
  • the collagen device made in accordance with the present invention is substantially fully resorbable, despite having a majority of its pores having a diameter of less than 10 ⁇ m.
  • the present inventors have found that despite the fact that those skilled in the art believe that the pore size must be sufficiently large enough (150 ⁇ m pore diameter is preferred for internal pores and 70 ⁇ m is preferred for surface pores) to permit growing meningeal tissue to infiltrate therein, the present invention collagen is replaced by growing meningeal tissue and is substantially fully resorbable even though a majority of its pores have a diameter of less than 10 ⁇ m.
  • a collagen device is prepared by mixing collagen with purified water for a period of time sufficient to form a mixture.
  • the pH of the mixture is adjusted to a pH level sufficient to substantially solubilize the collagen.
  • a first predetermined amount of the mixture is placed into a container.
  • the mixture is subject to a lyophilizing process and formed into a collagen device.
  • the collagen device is also cross-linked.
  • the collagen device has a plurality of pores wherein a majority of the pores have a diameter of less than 10 ⁇ m.
  • the collagen device is placed in contact with bodily tissue and that contact is maintained until the collagen device is substantially resorbed within the bodily tissue.
  • FIG. 1 is a flow chart illustrating a method of preparing a collagen device in accordance with the present invention
  • FIGS. 2A, 2B and 2 C are a lower perspective view, side view and top view respectively of a collagen device.
  • FIGS. 3A-3C show a collagen device made of a multi-layer or laminate product.
  • a collagen device in accordance with the present invention is prepared by mixing collagen with purified water for a period of time sufficient to form a mixture.
  • the ratio of collagen to purified water is between approximately 0.4% to 5.0% w/w.
  • the pH of the mixture is then adjusted to a pH level sufficient to substantially solubilize the collagen.
  • a predetermined amount of the mixture is then placed into a container.
  • the mixture is then formed into a collagen sheet by a lyophilizing process.
  • the mixture could also be formed into a block, cylinder, or other desired shape, which will hereinafter be referred to collectively as a collagen sheet.
  • the collagen sheet is then cross-linked.
  • the collagen sheet is preferably exposed to a liquid or vapor form of a cross-linking agent, such as formaldehyde or glutaraldehyde. Thereafter, the collagen sheet is ventilated if the cross-linking agent is vapor or relyophilized if it is liquid. The steps of forming the mixture into a collagen sheet and the cross-linking could be reversed.
  • a cross-linking agent such as formaldehyde or glutaraldehyde.
  • the resulting collagen sheet has a plurality of pores wherein a majority of the pores have a diameter of less than 10 ⁇ m.
  • a majority of the pores have a diameter of less than 10 ⁇ m.
  • greater than 80% of the pores have a diameter of less than 10 ⁇ m.
  • greater than 90% of the pores have a diameter of less than 10 ⁇ m.
  • greater than 95% of the pores have a diameter of less than 10 ⁇ m.
  • greater than 98% of the pores have a diameter of less than 10 ⁇ m.
  • approximately all of the pores have a diameter of less than 10 ⁇ m.
  • the collagen sheet 100 may be cut into predetermined shapes or formed in predetermined shapes that are formed to size.
  • Sheet 100 has a top surface 102 , bottom surface 104 and peripheral edge 106 .
  • the edge 106 of each predetermined shape may be chamfered to allow a smooth profile of the edge when it is wetted in situ, as shown in FIGS. 2A-2C .
  • the angle of the chamfer D is preferably approximately 30 to 75 degrees from vertical pivoting from the top or bottom surface.
  • the collagen sheet before cross-linking, can be compressed by rollers.
  • the collagen sheet can be compressed to between approximately one-half to one-eighths the original thickness C of the collagen sheet.
  • the collagen sheet may be placed in contact with bodily tissue.
  • contact between the collagen sheet and the bodily tissue is maintained.
  • time currently estimated to be about nine (9) months, the collagen sheet will be fully resorbed.
  • the collagen sheet does not stick to or adhere to instruments, including the surgeon's hands. Also, should the collagen sheet need to be repositioned, the surgeon is able to do so without the collagen sheet breaking apart.
  • the collagen sheet has very good strength properties, such as tensile strength, making it very easy to handle for the physician.
  • the collagen sheet in accordance with the present invention had an average tensile strength greater than 6.0 psi, ranging from 7.43 psi to 9.76 psi per lot, with an average of about 8.74 psi for all lots tested.
  • Currently available collagen sheets were tested and they had an average tensile strength of about 6.00 psi.
  • collagen device described herein can also be used to deliver biologically active agents such as, for example, growth factors, autologous cells, bone marrow, antibiotics, anti-cancer agents, and gene and DNA constructs.
  • biologically active agents such as, for example, growth factors, autologous cells, bone marrow, antibiotics, anti-cancer agents, and gene and DNA constructs.
  • the collagen device and method of preparing the same may be used to provide a component of a multi-layer or laminate product, as illustrated in FIGS. 3 A-C.
  • the collagen sheet 100 can include one or more layers or laminates 110 , 112 as shown ( FIG. 3A shows one laminate, and FIGS. 3B and 3C show two laminates).
  • the collagen sheet described can be laminated or otherwise attached with one or a number of the following: film, felt, woven or non-woven matrix, mesh or a second collagen sheet.
  • a collagen sheet as described may be combined with an impermeable film to provide a watertight construct.
  • the final multi-layer construct would be manufactured in order to improve one or a number of the following characteristics: suture retention strength, fluid impermeability, resorption duration, handling characteristics, stiffness, and/or adhesion properties to tissues.
  • the collagen sheet may include a layer of a film or woven matrix at the time of processing the collagen sheet so that it is incorporated within the boundaries of the collagen sheet.
  • An alternate method would be to apply the second layer to the collagen sheet by various methods including but not limited to adhesives, heat-pressing, and combining layers during partial processing of one or both materials.
  • the laminate or multi-layer product can include any biocompatible materials that may or may not be resorbable.
  • the layer added to the collagen device may have biological active agents (e.g., antibiotics, growth factors, hemostasis factors, anti-cancer agents) incorporated within or upon the material while it may or may not be on the collagen device.
  • the various dimensions of the laminate structures may vary from matching dimensions to one or multiple layers have greater or smaller dimensions than one of the other layers. In this manner, the preferential characteristics of one layer may be emphasized at a certain location as desired, depending upon the requirements of the surgical procedure.
  • the method includes a first step 12 of adding a collagen powder to purified water preferably in a ratio of approximately 0.4% to 5.0% w/w of collagen powder to purified water to hydrate the collagen powder.
  • a ratio of about 0.40% to about 3.50% w/w is even more preferred. While a ratio of about 0.60% to about 1.20% w/w is most preferred.
  • the collagen powder is commercially available from Datascope of 14 Phillips Parkway, Montvale, N.J.
  • the hydrated collagen is then mixed in step 14 with the purified water for a period of time sufficient to form a mixture.
  • this period of time is preferably from about three (3) to six (6) minutes.
  • the mixing is preferably achieved first with a relatively gentle mixer sufficient to solubilize the collagen with minimal or no shearing of the collagen fibers.
  • This gentle mixer may be a LightninTM mixer model L1U03 that mixes at 0 to 1000 rpm and is commercially available from Lightnin, which is a unit of General Signal of Coolock Dublin, Ireland.
  • the pH of the mixture is adjusted to a predetermined pH level in step 16 .
  • the predetermined pH level is preferably between approximately 1.5 and 4.0, which is below the isoelectric point of the mixture. In another embodiment, the predetermined pH level is preferably between approximately 11.0 and 13.5, which is above the isoelectric point of the mixture.
  • a timer is initiated, as illustrated in step 18 .
  • the pH of the mixture is preferably achieved while the mixture is being mixed with the gentle mixer at a mixing speed of between about 400 and 1000 rpm to a pH of about 3.0-3.2.
  • 1.0N HCl is preferably added to the mixture.
  • hydrochloric acid is preferably used to adjust the pH of the mixture, other acids may be used, such as, for example, acetic acid, lactic acid, or phosphoric acid.
  • the adjusting the pH step is preferably achieved without overshooting the predetermined pH level. If one were to overshoot the pH level, then an additive such as NaOH would have to be added to the mixture to raise the pH level.
  • Sodium hydroxide is preferably used to adjust the pH of the collagen solution, although other hydroxides may be used, such as, for example, other alkali metal hydroxides or ammonium hydroxides. But the present inventors have discovered that the raising and lowering or lowering and raising of the pH of the mixture may cause inconsistent freezing which may affect the desired pore size and biocompatibility due to the change in ionic strength. Thus, it is preferred not to overshoot the predetermined pH level.
  • the amount of HCl added to the mixture, the pH, and a calculation of the percentage of the solids concentration is determined, as illustrated in step 20 .
  • the mixture is continued to be mixed with the gentle mixer for preferably at least one (1) hour total elapsed time from the time the powder was added to the purified water in step 12 , as illustrated in step 22 .
  • the percentage of solids concentration is preferably within 0.6%-1.2%.
  • the mixture is mixed with a shear mixer preferably at a mixing speed of between about 8000 and 9000 rpm, as illustrated in step 24 .
  • the shear mixture preferably operates at a speed that is sufficient to mechanically break down the collagen powder.
  • This shear mixer may be a SilversonTM mixer that mixes at 0 to 10,000 rpm and is commercially available from Silverson Machines Limited of Waterside Chesham Bucks, England.
  • the pH of the mixture is preferably further adjusted while the mixture is being mixed with the shear mixer to a pH of about 3.4-3.6.
  • the viscosity of the mixture is measured in step 26 preferably with the initiation of mixing step 24 .
  • the pH is raised to improve sheet handling properties. This adjustment is preferably achieved without overshooting the predetermined pH level. If one were to overshoot the pH level, then an additive such as HCl would have to be added to the mixture to lower the pH level.
  • a predetermined amount of the mixture is placed into a container, as illustrated in step 30 .
  • a sufficient amount of the mixture is placed into the container so that the resultant collagen device will have sufficient thickness to perform as a dural substitute, adhesion barrier, or for short-term body contact for moisture retention, hemostasis, or tissue protection.
  • the tray is preferably made of a plastic material, such as PETG.
  • the trays could be made from glass, metal, ceramic, a base material coated with a non-stick surface such as TEFLON® or polished metal.
  • the trays could also be shaped with individual compartments with each compartment shaped to the desired final form of the collagen device.
  • the compartments can be of 1′′ ⁇ 1′′ square, with beveled edges on each edge. Of course, many different sizes or shapes could be made with or without beveled edges, including within the same tray, to meet the needs of the surgeon.
  • the container is placed in a chamber, as illustrated in step 32 .
  • the container is placed on a shelf within the chamber, and the shelf has a temperature control mechanism to control the temperature of the shelf, and thereby the chamber.
  • the temperature of the chamber will be referred to, but one skilled in the art will recognize that this includes the temperature of the shelf.
  • the temperature control mechanism is regulated so that the temperature of the chamber is preferably above the crystallization temperature of the mixture.
  • the bottom surface of the container is preferably planer to mate with the planer surface of the top surface of the shelf.
  • the temperature of the chamber can be at room temperature, which is between about 15 to 25° C. In another embodiment, the chamber can be about ⁇ 3° C. In yet another embodiment, the chamber temperature can be set well below the crystallization temperature of the mixture to about ⁇ 50° C. to deep freeze the mixture upon placement into the chamber. If the temperature is at room temperature, then the temperature of the chamber is adjusted to a second predetermined temperature approximately slightly above the crystallization temperature of the mixture over approximately a first predetermined time period, as illustrated in step 34 . Preferably, the second predetermined temperature is ⁇ 3° C. to ⁇ 5° C., and the first predetermined time period is approximately sixty (60) minutes. The chamber is then held at the second predetermined temperature for approximately forty-five (45) minutes.
  • the temperature of the chamber is the cooled to approximately ⁇ 45° C. over a period of approximately one (1) hour, as illustrated in step 36 .
  • the chamber is preferably held at this approximate temperature for about at least thirty (30) minutes.
  • a vacuum is then pulled in the chamber to approximately a first predetermined level sufficient to allow adequate sublimation of ice crystals the chamber is evacuated, as illustrated in step 38 .
  • the vacuum can be pulled while the temperature of the chamber is being held at ⁇ 45° C. in step 34 .
  • the chamber is evacuated to about 50-250 mTorr.
  • Sublimation of the ice crystals results in the formation of a collagen sheet having a plurality of pores wherein a majority of the pores have a diameter of less than 10 ⁇ m.
  • the chamber temperature is then raised to a sufficient temperature and held at this temperature for a sufficient period of time until primary drying occurs in the mixture, as illustrated in step 40 .
  • the chamber is ramped up to about ⁇ 5° C. over about five (5) hours and this temperature is maintained for about five (5) hours.
  • the mixture is transformed by the above steps into a collagen sheet.
  • the temperature of the chamber is then changed to approximately room temperature over approximately seven (7) hours.
  • the chamber is raised to about 35° C. over approximately three (3) hours and is held at this temperature for a sufficient period of time until secondary drying occurs in the collagen sheet without excessive drying or meltback, which in a currently preferred embodiment is for about seven (7) to twenty (20) hours.
  • the collagen sheet could be compressed by rollers or plates, as one skilled in the art will readily recognize.
  • the rollers can compress the sheet to between one-half to less than 5% of the sheets original thickness. Compressing the sheet may result in a collagen sheet that is stronger than conventional sheets.
  • the collagen sheet is then placed in a cross-linking chamber, as illustrated in step 44 .
  • the sheets of collagen can be hung in the cross-linking chamber or placed on screens. Of course, the sheets could remain in the same chamber, and the cross-linking processing could take place in this chamber.
  • a predetermined amount of a cross-linking agent is added to the cross-linking chamber in step 46 .
  • the predetermined amount of formaldehyde is sufficient to at least partially saturate the collagen sheet.
  • the cross-linking agent is formaldehyde, and the predetermined amount of formaldehyde is between approximately 25 ml and 35 ml. (Of course, the amount of formaldehyde added is dependent on the number of sheets and size of the chambers).
  • the collagen sheet is exposed to a liquid or vapor form of the cross-linking agent.
  • the cross-linking agent is removed from the cross-linking chamber after approximately sixteen (16) and twenty-four (24) hours in steps 48 and 50 .
  • the collagen sheet is preferably cross-linked by vapor cross-linking or solution cross-linking. If a solution is used, the sheet is preferably dehydrated by lyophilization.
  • Cross-linking agents such as formaldehyde, glutaraldehyde, carbodiimides or difunctional succinimides may be used.
  • the matrix may be cross-linked by dehydrothermal cross-linking or UV radiation.
  • the collagen sheets are ventilated for between approximately eight (8) and seventy (70) hours in step 52 , to remove excess cross-linking agent.
  • the collagen sheet is then cut into the desired shapes at a cutting station in step 54 .
  • the collagen sheet may be formed in predetermined shapes that are formed to size within the tray.
  • the edge of each predetermined shape may be chamfered to allow a smooth profile of the edge when it is wetted in situ.
  • the angle of the chamfer is preferably approximately 30 to 75 degrees from vertical.
  • Each cut section of the collagen sheet is then inspected, preferably visually, in step 56 . Thereafter, some samples can be sent for testing in step 58 and the remaining cut sections can be packaged in a conventional manner sterilized and then sent to the end user, in step 60 .
  • the collagen sheet is tested, preferably by test method ASTM E1294, to ensure that the porosity of the sheet is less than 10 ⁇ m in step 58 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
US10/955,835 2004-02-09 2004-09-30 Collagen device and method of preparing the same Abandoned US20050175659A1 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
US10/955,835 US20050175659A1 (en) 2004-02-09 2004-09-30 Collagen device and method of preparing the same
AU2005200378A AU2005200378B2 (en) 2004-02-09 2005-01-31 Collagen device and method of preparing the same
KR1020050010497A KR101232099B1 (ko) 2004-02-09 2005-02-04 콜라겐 장치 및 이의 제조방법
TW094103484A TWI445521B (zh) 2004-02-09 2005-02-04 膠原器件及其製備方法
CA2496187A CA2496187C (en) 2004-02-09 2005-02-08 Collagen device and method of preparing the same
EP10179803A EP2289570B1 (en) 2004-02-09 2005-02-08 Collagen device and method of preparing the same
ES05250694.6T ES2563305T3 (es) 2004-02-09 2005-02-08 Dispositivo de colágeno y procedimiento de preparación del mismo
ARP050100442A AR048064A1 (es) 2004-02-09 2005-02-08 Dispositivo de colageno y metodo para preparar el mismo
ES10179802.3T ES2626126T3 (es) 2004-02-09 2005-02-08 Dispositivo de colágeno y procedimiento de preparación del mismo
EP05250694.6A EP1561480B1 (en) 2004-02-09 2005-02-08 Collagen device and method of preparing the same
ES10179803T ES2398716T3 (es) 2004-02-09 2005-02-08 Dispositivo de colágeno y procedimiento de preparación del mismo
EP10179802.3A EP2289569B1 (en) 2004-02-09 2005-02-08 Collagen device and method of preparing the same
SG200500714A SG114709A1 (en) 2004-02-09 2005-02-08 Collagen device and method of preparing the same
CN 200510051850 CN1817371B (zh) 2004-09-30 2005-02-08 胶原构件及其制备方法
MXPA05001602A MXPA05001602A (es) 2004-02-09 2005-02-09 Dispositivo de colageno y metodo para preparar el mismo.
BRPI0500456A BRPI0500456A8 (pt) 2004-02-09 2005-02-09 Dispositivo de colágeno e método para preparar o mesmo
CO05062169A CO5590175A1 (es) 2004-09-30 2005-06-24 Dispositivo de colageno y metodo para preparar el mismo
US11/171,638 US20050283256A1 (en) 2004-02-09 2005-06-30 Collagen device and method of preparing the same
US12/196,621 US8795710B2 (en) 2004-02-09 2008-08-22 Collagen device and method of preparing the same
AU2011201382A AU2011201382B2 (en) 2004-02-09 2011-03-25 Collagen device and method of preparing the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54296804P 2004-02-09 2004-02-09
US56574704P 2004-04-27 2004-04-27
US10/955,835 US20050175659A1 (en) 2004-02-09 2004-09-30 Collagen device and method of preparing the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/171,638 Continuation-In-Part US20050283256A1 (en) 2004-02-09 2005-06-30 Collagen device and method of preparing the same

Publications (1)

Publication Number Publication Date
US20050175659A1 true US20050175659A1 (en) 2005-08-11

Family

ID=34682185

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/955,835 Abandoned US20050175659A1 (en) 2004-02-09 2004-09-30 Collagen device and method of preparing the same

Country Status (11)

Country Link
US (1) US20050175659A1 (ko)
EP (3) EP2289569B1 (ko)
KR (1) KR101232099B1 (ko)
AR (1) AR048064A1 (ko)
AU (2) AU2005200378B2 (ko)
BR (1) BRPI0500456A8 (ko)
CA (1) CA2496187C (ko)
ES (3) ES2398716T3 (ko)
MX (1) MXPA05001602A (ko)
SG (1) SG114709A1 (ko)
TW (1) TWI445521B (ko)

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1782848A3 (en) * 2005-09-29 2007-08-29 CODMAN & SHURTLEFF, INC. Dural graft and method of preparing the same
US20090004239A1 (en) * 2007-06-27 2009-01-01 Sebastien Ladet Dural repair material
US20090030526A1 (en) * 2004-02-09 2009-01-29 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
US20090068250A1 (en) * 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
EP2095832A1 (de) 2008-02-28 2009-09-02 Bayer MaterialScience AG Polyharnstoff-Systeme und deren Anwendung als postoperative Adhäsionsbarrieren, Filme und Verbundteile.
US20090269413A1 (en) * 2008-04-23 2009-10-29 Codman & Shurtleff, Inc. Flowable collagen material for dural closure
US20110020418A1 (en) * 2009-07-22 2011-01-27 Bosley Jr Rodney W Particulate Tissue Graft with Components of Differing Density and Methods of Making and Using the Same
US20110020420A1 (en) * 2009-07-22 2011-01-27 Bosley Jr Rodney W Variable Density Tissue Graft Composition and Methods of Making and Using the Same
WO2011138258A1 (en) 2010-05-05 2011-11-10 Aesculap Ag Medical hollow body implant
DE102010020662A1 (de) 2010-05-05 2011-11-10 Aesculap Ag Medizinisches Implantat
EP2612846A1 (de) 2012-01-09 2013-07-10 Bayer MaterialScience AG Beta-Aminosäureester und deren Verwendung
AU2012201918B2 (en) * 2005-09-29 2013-11-07 Integra Lifesciences Corporation Dural graft and method of preparing the same
US9242026B2 (en) 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
US9308068B2 (en) 2007-12-03 2016-04-12 Sofradim Production Implant for parastomal hernia
US9445883B2 (en) 2011-12-29 2016-09-20 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US9499927B2 (en) 2012-09-25 2016-11-22 Sofradim Production Method for producing a prosthesis for reinforcing the abdominal wall
US9526603B2 (en) 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
US9554887B2 (en) 2011-03-16 2017-01-31 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US9622843B2 (en) 2011-07-13 2017-04-18 Sofradim Production Umbilical hernia prosthesis
US9750837B2 (en) 2012-09-25 2017-09-05 Sofradim Production Haemostatic patch and method of preparation
US9839505B2 (en) 2012-09-25 2017-12-12 Sofradim Production Prosthesis comprising a mesh and a strengthening means
US9867909B2 (en) 2011-09-30 2018-01-16 Sofradim Production Multilayer implants for delivery of therapeutic agents
US9877820B2 (en) 2014-09-29 2018-01-30 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
US9932695B2 (en) 2014-12-05 2018-04-03 Sofradim Production Prosthetic porous knit
US9980802B2 (en) 2011-07-13 2018-05-29 Sofradim Production Umbilical hernia prosthesis
US10080639B2 (en) 2011-12-29 2018-09-25 Sofradim Production Prosthesis for inguinal hernia
US10159555B2 (en) 2012-09-28 2018-12-25 Sofradim Production Packaging for a hernia repair device
US10184032B2 (en) 2015-02-17 2019-01-22 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US10213283B2 (en) 2013-06-07 2019-02-26 Sofradim Production Textile-based prosthesis for laparoscopic surgery
US10327882B2 (en) 2014-09-29 2019-06-25 Sofradim Production Whale concept—folding mesh for TIPP procedure for inguinal hernia
US10363690B2 (en) 2012-08-02 2019-07-30 Sofradim Production Method for preparing a chitosan-based porous layer
US10405960B2 (en) 2013-06-07 2019-09-10 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film
US10646321B2 (en) 2016-01-25 2020-05-12 Sofradim Production Prosthesis for hernia repair
US10675137B2 (en) 2017-05-02 2020-06-09 Sofradim Production Prosthesis for inguinal hernia repair
US10682215B2 (en) 2016-10-21 2020-06-16 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US10743976B2 (en) 2015-06-19 2020-08-18 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10865505B2 (en) 2009-09-04 2020-12-15 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
US20210230526A1 (en) * 2016-06-28 2021-07-29 National Agriculture And Food Research Organization Cell enclosure device and use for same
US11471257B2 (en) 2018-11-16 2022-10-18 Sofradim Production Implants suitable for soft tissue repair
US12064330B2 (en) 2020-04-28 2024-08-20 Covidien Lp Implantable prothesis for minimally invasive hernia repair

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
US20070129630A1 (en) 2005-12-07 2007-06-07 Shimko Daniel A Imaging method, device and system
US7427293B2 (en) 2006-03-28 2008-09-23 Sdgi Holdings, Inc. Osteochondral plug graft, kit and method
US8846060B2 (en) 2006-01-12 2014-09-30 Integra Lifesciences Corporation Suturable dural and meningeal repair product comprising collagen matrix
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
EP2590693B1 (en) * 2010-06-28 2021-09-08 The Cleveland Clinic Foundation Reinforced tissue graft
CA2817584C (en) 2010-11-15 2018-01-02 Zimmer Orthobiologics, Inc. Bone void fillers
US9861348B2 (en) 2014-05-29 2018-01-09 Access Closure, Inc. Chitosan and polyethylene glycol copolymers and methods and devices for using same for sealing a vascular puncture
EP3034103A1 (en) 2014-12-15 2016-06-22 Geistlich Pharma AG Collagen Sponge
EP3165240A1 (en) 2015-11-05 2017-05-10 Ecole Polytechnique Federale De Lausanne (Epfl) Natural polymer-derived scaffold material and methods for production thereof
EP3442608B1 (en) 2016-04-13 2021-04-28 Regenosca SA Non-uniformly stiff polymeric scaffolds and methods for producing thereof
US11679177B2 (en) 2017-08-08 2023-06-20 Baxter International Inc. Polymeric compositions, delivery devices, and methods
CN114225113B (zh) * 2021-12-21 2022-10-14 西安德诺海思医疗科技有限公司 一种双层结构可降解的人工硬脑膜及其制备方法

Citations (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US380792A (en) * 1888-04-10 eggis
US2465357A (en) * 1944-08-14 1949-03-29 Upjohn Co Therapeutic sponge and method of making
US2492458A (en) * 1944-12-08 1949-12-27 Jr Edgar A Bering Fibrin foam
US3157524A (en) * 1960-10-25 1964-11-17 Ethicon Inc Preparation of collagen sponge
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US3520402A (en) * 1967-08-30 1970-07-14 Ethicon Inc Purified collagen fibrils
US3632361A (en) * 1969-06-26 1972-01-04 Fmc Corp Water-insoluble microcrystalline collagen absorbent mat
US3742955A (en) * 1970-09-29 1973-07-03 Fmc Corp Fibrous collagen derived product having hemostatic and wound binding properties
US3939831A (en) * 1974-03-04 1976-02-24 Intreprinderea Flacara Rosie Process for preparing medicinal dressings
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4016887A (en) * 1973-06-21 1977-04-12 Miroslav Uroshevich Two-stage tobacco smoke filter
US4066083A (en) * 1976-06-03 1978-01-03 Pentapharm A.G. Sterile surgical collagen product
US4089333A (en) * 1972-10-28 1978-05-16 Nippi, Incorporated Method of treating a wound or burn
US4140537A (en) * 1975-10-22 1979-02-20 Collagen Corporation Aqueous collagen composition
US4148664A (en) * 1976-05-10 1979-04-10 Avicon, Inc. Preparation of fibrous collagen product having hemostatic and wound sealing properties
US4185011A (en) * 1978-10-16 1980-01-22 Firma Carl Freudenberg Process for the production of collagen fibers
US4215200A (en) * 1978-10-02 1980-07-29 Cornell Research Foundation, Inc. Chemically and enzymatically modified collagen hemostatic agent
US4233360A (en) * 1975-10-22 1980-11-11 Collagen Corporation Non-antigenic collagen and articles of manufacture
US4238480A (en) * 1978-05-19 1980-12-09 Sawyer Philip Nicholas Method for preparing an improved hemostatic agent and method of employing the same
US4271070A (en) * 1980-05-05 1981-06-02 Cornell Research Foundation, Inc. Chemically-modified fiber collagen hemostatic agents
US4294241A (en) * 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4404033A (en) * 1980-05-30 1983-09-13 Chemokol Gesellschaft Zur Entwicklung Von Kollagenprodukten Method of making collagen fibers for surgical use
US4404970A (en) * 1978-05-19 1983-09-20 Sawyer Philip Nicholas Hemostatic article and methods for preparing and employing the same
US4407787A (en) * 1980-10-03 1983-10-04 Dr. Ruhland Nachf. Gmbh Collagenous dressing
US4412947A (en) * 1979-09-12 1983-11-01 Seton Company Collagen sponge
US4522753A (en) * 1980-07-17 1985-06-11 Massachusetts Institute Of Technology Method for preserving porosity in porous materials
US4578067A (en) * 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
US4600533A (en) * 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
US4606910A (en) * 1984-06-28 1986-08-19 Interface Biomedical Laboratories Composite hemostatic article including a hemostatic agent onlay and methods for preparing the same
US4738849A (en) * 1984-06-28 1988-04-19 Interface Biomedical Laboratories Corp. Composite medical articles for application to wounds and method for producing same
US4798800A (en) * 1984-03-19 1989-01-17 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Process for isolating human globular domain NC1 of basal membrane collagen from human tissue
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
US4948540A (en) * 1988-08-01 1990-08-14 Semex Medical, Inc. Method of preparing collagen dressing sheet material
US4947840A (en) * 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
US4970298A (en) * 1984-03-27 1990-11-13 University Of Medicine And Dentistry Of New Jersey Biodegradable matrix and methods for producing same
US5019087A (en) * 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US5110604A (en) * 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
US5201745A (en) * 1988-03-15 1993-04-13 Imedex Visceral surgery patch
US5215904A (en) * 1989-01-27 1993-06-01 Wisconsin Alumni Research Foundation Method for producing a recombinant mammal in vivo
US5227301A (en) * 1989-11-03 1993-07-13 The 501 Institution For The Advancement Of Learning (Mcgill University) Immortalized bovine mannary epithelial cell line
US5412076A (en) * 1992-06-18 1995-05-02 Flamel Technologies Crosslinkable collagen derivatives, process for their production and their application to the preparation of biomaterials
US5512301A (en) * 1992-05-01 1996-04-30 Amgen Inc. Collagen-containing sponges as drug delivery compositions for proteins
US5567806A (en) * 1991-08-02 1996-10-22 Abdul-Malak; Nabil Collagen crosslinked with a crosslinking agent for the manufacture of a suturable, biocompatible slowresorbing membrane, and such a membrane
US5580923A (en) * 1995-03-14 1996-12-03 Collagen Corporation Anti-adhesion films and compositions for medical use
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
US5931800A (en) * 1993-12-23 1999-08-03 Acacia Laboratories Of Texas, Inc. Wound dressing delivery system and method of manufacturing a wound dressing delivery system
US5997895A (en) * 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US6270793B1 (en) * 1999-09-13 2001-08-07 Keraplast Technologies, Ltd. Absorbent keratin wound dressing
US6274155B1 (en) * 1999-09-13 2001-08-14 Keraplast Technologies, Ltd. Nonwoven sheet and film containing water absorbent keratin
US6361551B1 (en) * 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
US6454787B1 (en) * 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
US6461628B1 (en) * 1999-09-13 2002-10-08 Keraplast Technologies, Ltd. Non-woven keratin cell scaffold
US20030220334A1 (en) * 1999-11-30 2003-11-27 Wender Paul A. Byrostatin analogues, synthetic methods and uses
US20040028738A1 (en) * 2000-10-05 2004-02-12 Lynn L.H. Huang Process for the preparation of porous collagen matrix

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07100B2 (ja) * 1990-01-31 1995-01-11 グンゼ株式会社 コラーゲンスポンジの乾燥法
US5206028A (en) * 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
TW501934B (en) * 1996-11-20 2002-09-11 Tapic Int Co Ltd Collagen material and process for making the same
EP1017415B1 (en) * 1997-09-16 2005-10-19 Integra Lifesciences Corporation Product for promoting dural or meningeal tissue growth comprising collagen
JP2003525705A (ja) * 2000-03-09 2003-09-02 シンタコール アーゲー 組織再構築用の多層コラーゲンマトリックス

Patent Citations (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US380792A (en) * 1888-04-10 eggis
US2465357A (en) * 1944-08-14 1949-03-29 Upjohn Co Therapeutic sponge and method of making
US2492458A (en) * 1944-12-08 1949-12-27 Jr Edgar A Bering Fibrin foam
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US3157524A (en) * 1960-10-25 1964-11-17 Ethicon Inc Preparation of collagen sponge
US3520402A (en) * 1967-08-30 1970-07-14 Ethicon Inc Purified collagen fibrils
US3632361A (en) * 1969-06-26 1972-01-04 Fmc Corp Water-insoluble microcrystalline collagen absorbent mat
US3742955A (en) * 1970-09-29 1973-07-03 Fmc Corp Fibrous collagen derived product having hemostatic and wound binding properties
US4089333A (en) * 1972-10-28 1978-05-16 Nippi, Incorporated Method of treating a wound or burn
US4016887A (en) * 1973-06-21 1977-04-12 Miroslav Uroshevich Two-stage tobacco smoke filter
US3939831A (en) * 1974-03-04 1976-02-24 Intreprinderea Flacara Rosie Process for preparing medicinal dressings
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4140537A (en) * 1975-10-22 1979-02-20 Collagen Corporation Aqueous collagen composition
US4233360A (en) * 1975-10-22 1980-11-11 Collagen Corporation Non-antigenic collagen and articles of manufacture
US4148664A (en) * 1976-05-10 1979-04-10 Avicon, Inc. Preparation of fibrous collagen product having hemostatic and wound sealing properties
US4066083A (en) * 1976-06-03 1978-01-03 Pentapharm A.G. Sterile surgical collagen product
US4294241A (en) * 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4404970A (en) * 1978-05-19 1983-09-20 Sawyer Philip Nicholas Hemostatic article and methods for preparing and employing the same
US4238480A (en) * 1978-05-19 1980-12-09 Sawyer Philip Nicholas Method for preparing an improved hemostatic agent and method of employing the same
US4215200A (en) * 1978-10-02 1980-07-29 Cornell Research Foundation, Inc. Chemically and enzymatically modified collagen hemostatic agent
US4185011A (en) * 1978-10-16 1980-01-22 Firma Carl Freudenberg Process for the production of collagen fibers
US4412947A (en) * 1979-09-12 1983-11-01 Seton Company Collagen sponge
US4271070A (en) * 1980-05-05 1981-06-02 Cornell Research Foundation, Inc. Chemically-modified fiber collagen hemostatic agents
US4404033A (en) * 1980-05-30 1983-09-13 Chemokol Gesellschaft Zur Entwicklung Von Kollagenprodukten Method of making collagen fibers for surgical use
US4522753A (en) * 1980-07-17 1985-06-11 Massachusetts Institute Of Technology Method for preserving porosity in porous materials
US4407787A (en) * 1980-10-03 1983-10-04 Dr. Ruhland Nachf. Gmbh Collagenous dressing
US4578067A (en) * 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
US4798800A (en) * 1984-03-19 1989-01-17 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Process for isolating human globular domain NC1 of basal membrane collagen from human tissue
US4970298A (en) * 1984-03-27 1990-11-13 University Of Medicine And Dentistry Of New Jersey Biodegradable matrix and methods for producing same
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
US4738849A (en) * 1984-06-28 1988-04-19 Interface Biomedical Laboratories Corp. Composite medical articles for application to wounds and method for producing same
US4606910A (en) * 1984-06-28 1986-08-19 Interface Biomedical Laboratories Composite hemostatic article including a hemostatic agent onlay and methods for preparing the same
US4600533A (en) * 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
US4725671A (en) * 1984-12-24 1988-02-16 Collagen Corporation Collagen membranes for medical use
US4689399A (en) * 1984-12-24 1987-08-25 Collagen Corporation Collagen membranes for medical use
US4655980A (en) * 1984-12-24 1987-04-07 Collagen Corporation Process of making collagen membranes for medical use
US5019087A (en) * 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US4947840A (en) * 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
US5201745A (en) * 1988-03-15 1993-04-13 Imedex Visceral surgery patch
US5110604A (en) * 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
US4948540A (en) * 1988-08-01 1990-08-14 Semex Medical, Inc. Method of preparing collagen dressing sheet material
US5215904A (en) * 1989-01-27 1993-06-01 Wisconsin Alumni Research Foundation Method for producing a recombinant mammal in vivo
US5227301A (en) * 1989-11-03 1993-07-13 The 501 Institution For The Advancement Of Learning (Mcgill University) Immortalized bovine mannary epithelial cell line
US5567806A (en) * 1991-08-02 1996-10-22 Abdul-Malak; Nabil Collagen crosslinked with a crosslinking agent for the manufacture of a suturable, biocompatible slowresorbing membrane, and such a membrane
US5512301A (en) * 1992-05-01 1996-04-30 Amgen Inc. Collagen-containing sponges as drug delivery compositions for proteins
US5412076A (en) * 1992-06-18 1995-05-02 Flamel Technologies Crosslinkable collagen derivatives, process for their production and their application to the preparation of biomaterials
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
US5931800A (en) * 1993-12-23 1999-08-03 Acacia Laboratories Of Texas, Inc. Wound dressing delivery system and method of manufacturing a wound dressing delivery system
US5580923A (en) * 1995-03-14 1996-12-03 Collagen Corporation Anti-adhesion films and compositions for medical use
US5997895A (en) * 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US6454787B1 (en) * 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
US6361551B1 (en) * 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
US6274155B1 (en) * 1999-09-13 2001-08-14 Keraplast Technologies, Ltd. Nonwoven sheet and film containing water absorbent keratin
US6270793B1 (en) * 1999-09-13 2001-08-07 Keraplast Technologies, Ltd. Absorbent keratin wound dressing
US6461628B1 (en) * 1999-09-13 2002-10-08 Keraplast Technologies, Ltd. Non-woven keratin cell scaffold
US20030220334A1 (en) * 1999-11-30 2003-11-27 Wender Paul A. Byrostatin analogues, synthetic methods and uses
US20040028738A1 (en) * 2000-10-05 2004-02-12 Lynn L.H. Huang Process for the preparation of porous collagen matrix

Cited By (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8795710B2 (en) 2004-02-09 2014-08-05 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
US20090030526A1 (en) * 2004-02-09 2009-01-29 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
EP2399617B1 (en) 2005-06-30 2016-05-18 Codman & Shurtleff, Inc. Dural graft material comprising collagen
US20080208359A1 (en) * 2005-09-29 2008-08-28 Codman & Shurtleff, Inc. Dural graft and method of preparing the same
AU2012201918B2 (en) * 2005-09-29 2013-11-07 Integra Lifesciences Corporation Dural graft and method of preparing the same
EP1782848A3 (en) * 2005-09-29 2007-08-29 CODMAN & SHURTLEFF, INC. Dural graft and method of preparing the same
AU2006222757B2 (en) * 2005-09-29 2012-04-12 Integra Lifesciences Corporation Dural graft and method of preparing the same
US20090004239A1 (en) * 2007-06-27 2009-01-01 Sebastien Ladet Dural repair material
US8932619B2 (en) 2007-06-27 2015-01-13 Sofradim Production Dural repair material
US20090068250A1 (en) * 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
US9750846B2 (en) 2007-09-07 2017-09-05 Sofradim Production Sas Bioresorbable and biocompatible compounds for surgical use
US9308068B2 (en) 2007-12-03 2016-04-12 Sofradim Production Implant for parastomal hernia
US10368971B2 (en) 2007-12-03 2019-08-06 Sofradim Production Implant for parastomal hernia
EP2095832A1 (de) 2008-02-28 2009-09-02 Bayer MaterialScience AG Polyharnstoff-Systeme und deren Anwendung als postoperative Adhäsionsbarrieren, Filme und Verbundteile.
US10633481B2 (en) 2008-02-28 2020-04-28 Adhesys Medical Gmbh Polyurea systems, processes for preparing the same and use thereof for postoperative adhesion barriers
EP3097929A1 (de) 2008-02-28 2016-11-30 Adhesys Medical GmbH Postoperative adhäsionsbarrieren
EP3653235A1 (de) 2008-02-28 2020-05-20 Adhesys Medical GmbH Postoperative adhäsionsbarrieren
US9000089B2 (en) 2008-02-28 2015-04-07 Medical Adhesive Revolution Gmbh Polyurea systems, processes for preparing the same and use thereof for postoperative adhesion barriers
US20090221071A1 (en) * 2008-02-28 2009-09-03 Bayer Materialscience Ag Polyurea Systems, Processes for Preparing the Same and Use Thereof for Postoperative Adhesion Barriers
US8039591B2 (en) 2008-04-23 2011-10-18 Codman & Shurtleff, Inc. Flowable collagen material for dural closure
US20090269413A1 (en) * 2008-04-23 2009-10-29 Codman & Shurtleff, Inc. Flowable collagen material for dural closure
US10070948B2 (en) 2008-06-27 2018-09-11 Sofradim Production Biosynthetic implant for soft tissue repair
US9242026B2 (en) 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
US11000628B2 (en) 2009-07-22 2021-05-11 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US11013829B2 (en) 2009-07-22 2021-05-25 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US8968761B2 (en) 2009-07-22 2015-03-03 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US8652500B2 (en) 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US9056078B2 (en) 2009-07-22 2015-06-16 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US8541032B2 (en) 2009-07-22 2013-09-24 Acell, Inc. Tissue graft composition
US10517994B2 (en) 2009-07-22 2019-12-31 Acell, Inc. Variable density tissue graft composition and methods of making and using the same
US10898610B2 (en) 2009-07-22 2021-01-26 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US20110020420A1 (en) * 2009-07-22 2011-01-27 Bosley Jr Rodney W Variable Density Tissue Graft Composition and Methods of Making and Using the Same
US20110020418A1 (en) * 2009-07-22 2011-01-27 Bosley Jr Rodney W Particulate Tissue Graft with Components of Differing Density and Methods of Making and Using the Same
US8298586B2 (en) 2009-07-22 2012-10-30 Acell Inc Variable density tissue graft composition
US8962035B2 (en) 2009-07-22 2015-02-24 Acell, Inc. Variable density tissue graft composition and methods of making and using the same
US9579183B2 (en) 2009-07-22 2017-02-28 Acell, Inc. Variable density tissue graft composition and methods of making and using the same
US9561307B2 (en) 2009-07-22 2017-02-07 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US11970798B2 (en) 2009-09-04 2024-04-30 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
US10865505B2 (en) 2009-09-04 2020-12-15 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
DE102010020663A1 (de) 2010-05-05 2011-11-10 Aesculap Ag Medizinisches Hohlkörperimplantat
DE102010020662A1 (de) 2010-05-05 2011-11-10 Aesculap Ag Medizinisches Implantat
WO2011138256A1 (en) 2010-05-05 2011-11-10 Aesculap Ag Medical implant
WO2011138258A1 (en) 2010-05-05 2011-11-10 Aesculap Ag Medical hollow body implant
US9554887B2 (en) 2011-03-16 2017-01-31 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US10472750B2 (en) 2011-03-16 2019-11-12 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US11612472B2 (en) 2011-03-16 2023-03-28 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US9622843B2 (en) 2011-07-13 2017-04-18 Sofradim Production Umbilical hernia prosthesis
US9980802B2 (en) 2011-07-13 2018-05-29 Sofradim Production Umbilical hernia prosthesis
US11039912B2 (en) 2011-07-13 2021-06-22 Sofradim Production Umbilical hernia prosthesis
US11903807B2 (en) 2011-07-13 2024-02-20 Sofradim Production Umbilical hernia prosthesis
US10709538B2 (en) 2011-07-13 2020-07-14 Sofradim Production Umbilical hernia prosthesis
US9867909B2 (en) 2011-09-30 2018-01-16 Sofradim Production Multilayer implants for delivery of therapeutic agents
US9526603B2 (en) 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
US11925543B2 (en) 2011-12-29 2024-03-12 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US10342652B2 (en) 2011-12-29 2019-07-09 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US11266489B2 (en) 2011-12-29 2022-03-08 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US11471256B2 (en) 2011-12-29 2022-10-18 Sofradim Production Prosthesis for inguinal hernia
US10080639B2 (en) 2011-12-29 2018-09-25 Sofradim Production Prosthesis for inguinal hernia
US9445883B2 (en) 2011-12-29 2016-09-20 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
EP2612846A1 (de) 2012-01-09 2013-07-10 Bayer MaterialScience AG Beta-Aminosäureester und deren Verwendung
WO2013104564A1 (de) 2012-01-09 2013-07-18 Bayer Intellectual Property Gmbh Beta-aminosäureester und deren verwendung
US10363690B2 (en) 2012-08-02 2019-07-30 Sofradim Production Method for preparing a chitosan-based porous layer
US9839505B2 (en) 2012-09-25 2017-12-12 Sofradim Production Prosthesis comprising a mesh and a strengthening means
US9750837B2 (en) 2012-09-25 2017-09-05 Sofradim Production Haemostatic patch and method of preparation
US9499927B2 (en) 2012-09-25 2016-11-22 Sofradim Production Method for producing a prosthesis for reinforcing the abdominal wall
US10159555B2 (en) 2012-09-28 2018-12-25 Sofradim Production Packaging for a hernia repair device
US11304790B2 (en) 2013-06-07 2022-04-19 Sofradim Production Textile-based prothesis for laparoscopic surgery
US12059338B2 (en) 2013-06-07 2024-08-13 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10213283B2 (en) 2013-06-07 2019-02-26 Sofradim Production Textile-based prosthesis for laparoscopic surgery
US11622845B2 (en) 2013-06-07 2023-04-11 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10405960B2 (en) 2013-06-07 2019-09-10 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film
US12070534B2 (en) 2014-09-24 2024-08-27 Sofradim Production Method for preparing an anti-adhesion barrier film
US11291536B2 (en) 2014-09-29 2022-04-05 Sofradim Production Whale concept-folding mesh for TIPP procedure for inguinal hernia
US10653508B2 (en) 2014-09-29 2020-05-19 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US11589974B2 (en) 2014-09-29 2023-02-28 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US9877820B2 (en) 2014-09-29 2018-01-30 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US10327882B2 (en) 2014-09-29 2019-06-25 Sofradim Production Whale concept—folding mesh for TIPP procedure for inguinal hernia
US11713526B2 (en) 2014-12-05 2023-08-01 Sofradim Production Prosthetic porous knit
US11359313B2 (en) 2014-12-05 2022-06-14 Sofradim Production Prosthetic porous knit
US10745835B2 (en) 2014-12-05 2020-08-18 Sofradim Production Prosthetic porous knit
US9932695B2 (en) 2014-12-05 2018-04-03 Sofradim Production Prosthetic porous knit
US12091788B2 (en) 2014-12-05 2024-09-17 Sofradim Production Prosthetic porous knit
US10815345B2 (en) 2015-02-17 2020-10-27 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US10184032B2 (en) 2015-02-17 2019-01-22 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US10660741B2 (en) 2015-04-24 2020-05-26 Sofradim Production Prosthesis for supporting a breast structure
US11439498B2 (en) 2015-04-24 2022-09-13 Sofradim Production Prosthesis for supporting a breast structure
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
US11826242B2 (en) 2015-06-19 2023-11-28 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10743976B2 (en) 2015-06-19 2020-08-18 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US11389282B2 (en) 2016-01-25 2022-07-19 Sofradim Production Prosthesis for hernia repair
US10646321B2 (en) 2016-01-25 2020-05-12 Sofradim Production Prosthesis for hernia repair
US20210230526A1 (en) * 2016-06-28 2021-07-29 National Agriculture And Food Research Organization Cell enclosure device and use for same
US11696819B2 (en) 2016-10-21 2023-07-11 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US10682215B2 (en) 2016-10-21 2020-06-16 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US11672636B2 (en) 2017-05-02 2023-06-13 Sofradim Production Prosthesis for inguinal hernia repair
US10675137B2 (en) 2017-05-02 2020-06-09 Sofradim Production Prosthesis for inguinal hernia repair
US11471257B2 (en) 2018-11-16 2022-10-18 Sofradim Production Implants suitable for soft tissue repair
US12064330B2 (en) 2020-04-28 2024-08-20 Covidien Lp Implantable prothesis for minimally invasive hernia repair

Also Published As

Publication number Publication date
KR20060041726A (ko) 2006-05-12
EP2289570B1 (en) 2012-12-26
EP2289570A2 (en) 2011-03-02
TWI445521B (zh) 2014-07-21
TW200533325A (en) 2005-10-16
BRPI0500456A (pt) 2005-10-11
CA2496187C (en) 2013-04-09
EP1561480B1 (en) 2015-12-02
ES2626126T3 (es) 2017-07-24
ES2398716T3 (es) 2013-03-21
EP2289569A2 (en) 2011-03-02
AU2005200378B2 (en) 2010-12-23
EP2289570A3 (en) 2011-08-10
CA2496187A1 (en) 2005-08-09
ES2563305T3 (es) 2016-03-14
AU2011201382B2 (en) 2013-09-12
SG114709A1 (en) 2005-09-28
AR048064A1 (es) 2006-03-29
AU2011201382A1 (en) 2011-05-12
EP2289569A3 (en) 2011-08-10
EP1561480A2 (en) 2005-08-10
KR101232099B1 (ko) 2013-02-12
EP1561480A3 (en) 2006-03-15
BRPI0500456A8 (pt) 2018-06-12
EP2289569B1 (en) 2017-03-22
MXPA05001602A (es) 2006-03-08
AU2005200378A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
CA2496187C (en) Collagen device and method of preparing the same
US8795710B2 (en) Collagen device and method of preparing the same
US8460686B2 (en) Bioactive bone graft substitute
US8556990B2 (en) Reinforced PTFE medical barriers
DK2517738T3 (en) A COLLAGEN / HYDROXYAPATITE COMPOSITE SCAFFOLD
US20090317447A1 (en) Biodegradable bone graft for orthopedic use
US20050214340A1 (en) Pliable conformable bone restorative
Rakhmatia et al. Microcomputed tomographic and histomorphometric analyses of novel titanium mesh membranes for guided bone regeneration: a study in rat calvarial defects.
Dziedzic et al. Osteoconduction on, and bonding to, calcium phosphate ceramic implants
JP5551712B2 (ja) 形成方法および手術部位保存のための得られた膜組成物
ES2578907T3 (es) Dispositivo bioimplantable de colageno
CN1817371B (zh) 胶原构件及其制备方法

Legal Events

Date Code Title Description
AS Assignment

Owner name: CODMAN & SHURTLEFF, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MACOMBER, LAUREL R.;SOMMERICH, ROBERT E.;SHENOY, VIVEK N.;AND OTHERS;REEL/FRAME:015859/0975;SIGNING DATES FROM 20040929 TO 20040930

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION